ArticleJournal of magnetic resonance imaging : JMRI2024
Dark Blood Contrast-Enhanced Brain MRI Using Echo-uT
Article in Journal of magnetic resonance imaging : JMRI, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- T1 Relaxation-Enhanced Steady-State Acquisition With Radial k-Space Sampling: A Novel Family of Pulse Sequences for Motion-Robust Volumetric T1-Weighted MRI With Improved Lesion Conspicuity.Investigative radiology · 2025Article
- Prospective comparison of brain tumor detection and characterization using post-contrast Dixon uT1RESS and MPRAGE at 3 Tesla.European journal of radiology · 2025Article
- 3 Tesla stack-of-stars echo unbalanced T1 relaxation-enhanced steady-state MRI for brain tumor imaging: post-contrast comparison with MPRAGE.Cancer imaging : the official publication of the International Cancer Imaging Society · 2025Observational
- Applications and Efficacy of Iron Oxide Nanoparticles in the Treatment of Brain Tumors.Pharmaceutics · 2025Review
Corrections and comments
- Commented on by
Authors and funding
8 authors.
Funding
Abstract
backgroundThe widely used magnetization-prepared rapid gradient-echo (MPRAGE) sequence makes enhancing lesions and blood vessels appear bright after gadolinium administration. However, dark blood imaging using T1-weighted Sampling Perfection with Application optimized Contrast using different flip angle Evolution (T1 SPACE) can be advantageous since it improves the conspicuity of small metastases and leptomeningeal disease. As a potential alternative to T1 SPACE, we evaluated a new dark blood sequence called echo-uT PURPOSE: We compared the performance of echo-uT STUDY TYPE: Retrospective, IRB approved. SUBJECTS/PHANTOM: Phantom to assess flow properties of echo-uT FIELD STRENGTH/SEQUENCES: 3 Tesla/MPRAGE, T1 SPACE, Dixon fid-uT ASSESSMENT: Flow phantom signal vs. velocity as a function of flip angle and sequence. Qualitative image assessment on 4-point scale. Quantitative evaluation of tumor-to-brain contrast, apparent contrast-to-noise ratio (aCNR), and vessel-to-brain aCNR. STATISTICAL TESTS: Friedman and Mann-Whitney U tests. A P value <0.05 was considered statistically significant.
resultsIn the phantom, echo-uT DATA
conclusionVolumetric dark blood contrast-enhanced brain MRI is feasible using echo-uT EVIDENCE LEVEL: 3 TECHNICAL EFFICACY: Stage 1.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.